•
Jun 30, 2022

ImmunityBio Q2 2022 Earnings Report

Total Revenue
$35K
Previous year: $339K
-89.7%
EPS
-$0.24
Previous year: -$0.23
+4.3%
Gross Profit
-$5.9M
Previous year: $339K
-1839.2%
Cash and Equivalents
$61.9M
Previous year: $84M
-26.3%
Free Cash Flow
-$107M
Previous year: -$77.6M
+38.1%
Total Assets
$318M
Previous year: $246M
+29.0%

ImmunityBio

ImmunityBio

ImmunityBio Revenue by Segment